Amrita Hospital, Kochi, launches ILD and Sarcoidosis Clinics for severe lung conditions, ET HealthWorld


Kochi/ JAN 11, 2024: The first-ever dedicated sarcoidosis clinic and the ILD (interstitial lung disease) clinic were opened by Amrita Hospital in Kochi. This historic introduction, which aims to address the mounting issues related to respiratory illnesses, represents a revolutionary step forward in South Indian healthcare services.

These cutting-edge clinics have been carefully planned to address sarcoidosis, pulmonology problems, and suspected or confirmed intestinal illnesses. They bring together a committed group of multidisciplinary specialists, such as pathologists, radiologists, pulmonologists, and rheumatologists, who are all committed to offering comprehensive care and support to people with Sarcoidosis or ILD.

During the inauguration ceremony at BUILD Summit-24, organized in collaboration with the Indian Chest Society, Professor Athol Wells, a distinguished expert in Respiratory Medicine from Imperial College, London, officially inaugurated the specialized clinics. Emphasizing the significance of these clinics, Professor Wells remarked, “The launch of both these clinics broadens the scope of diagnosis and treatment, prioritizing a patient-centric approach to enhance the overall quality of life. These clinics offer a valuable opportunity to address the pressing healthcare needs associated with Sarcoidosis and ILDs, marking a significant leap forward in healthcare services in Kerala and adjacent states. It is a privilege to witness the clinic’s opening, highlighting the critical need for its services. Raising awareness among general practitioners and paramedical professionals is crucial to considering the possibility of interstitial lung disease early in the diagnostic process. The general public may not prioritize these disorders, it is within the medical community’s hands to enhance awareness and expedite diagnosis for improved patient outcomes.”There are two different respiratory conditions: interstitial lung disease (ILD) and sarcoidosis. Sarcoidosis is an uncommon inflammatory disease that mostly affects the lymph nodes and lungs. It is generally brought on by unexplained causes and is treated with corticosteroids. ILD is a collective term for a set of lung conditions marked by inflammation and scarring of the interstitial tissue, including autoimmune illnesses and environmental factors among their causes. Breathlessness and coughing are among the symptoms; treatment options vary based on the kind of ILD and may include oxygen therapy, medication, or lung transplantation. For both illnesses, a complete medical evaluation is necessary to ensure an accurate diagnosis and the best course of treatment.Dr. Asmita Mehta, Professor and Head of the Department of Respiratory Medicine, Amrita Hospital, Kochi emphasizes the integral role of the launch in reshaping healthcare delivery dynamics in Kerala and India. She stated, “The inauguration of two groundbreaking clinics focusing respiratory conditions marks a significant milestone in healthcare. With ILD prevalence on the rise, managing these intricate respiratory conditions has become increasingly demanding in India. These clinics are a testament to our commitment to providing specialized care, addressing a pressing need in the healthcare landscape, and enhancing patient outcomes.”The ILD Clinic addresses a critical need for treating this rare lung condition that often requires lung transplants, though still in its early stages in India. Unfortunately, with a survival rate of around 5 years and a higher incidence in male smokers above 60, the potential for fatality is a concern. Conversely, the ‘Sarcoidosis Clinic’ focuses on a curable condition that if started swift treatment can be cured within a span of 2 years. These clinics mark significant progress in addressing complex medical challenges and is a vital initiative designed to confront the escalating challenges posed by these conditions in the Indian landscape.

  • Published On Jan 12, 2024 at 07:20 AM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles

Scan to download App


Leave a Reply

Your email address will not be published. Required fields are marked *